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Background: Despite advances in operative repair, ruptured abdominal aortic aneurysm 
(rAAA) remains associated with high mortality and morbidity rates, especially in elderly 
patients. The purpose of this study was to evaluate the outcomes of emergency endovascular 
aneurysm repair (eEVAR), conventional open repair (OPEN), and conservative treatment in 
elderly patients with rAAA.
Methods: We conducted a retrospective study of all rAAA patients treated with OPEN or 
eEVAR between January 2005 and December 2011 in the vascular surgery department at 
Amphia Hospital, the Netherlands. The outcome in patients treated for rAAA by eEVAR or 
OPEN repair was investigated. Special attention was paid to patients who were admitted and 
did not receive operative intervention due to serious comorbidity, extremely advanced age, 
or poor physical condition. We calculated the 30-day rAAA-related mortality for all rAAA 
patients admitted to our hospital.
Results: Twelve patients did not receive operative emergency repair due to extreme fragility 
(mean age 87 years, median time to mortality 27 hours). Twenty-three patients had eEVAR and 82 
had OPEN surgery. The 30-day mortality rate in operated patients was 30% (7/23) in the eEVAR 
group versus 26% (21/82) in the OPEN group (P=0.64). No difference in mortality was noted 
between eEVAR and OPEN over 5 years of follow-up. There were more cardiac adverse events 
in the OPEN group (n=25, 31%) than in the eEVAR group (n=2, 9%; P=0.035). Reintervention 
after discharge was more frequent in patients who received eEVAR (35%) than in patients who 
had OPEN (6%, P0.001). Advancing age was associated with increasing mortality (hazard ratio 
1.05 [95% confidence interval 1.01–1.09]) per year for patients who received operative repair, 
with a 67%, 76%, and 100% 5-year mortality rate in the 34 patients aged 70 years, 59 patients 
aged 70–79 years, and 12 octogenarians, respectively; 30-day rAAA-related mortality was also 
associated with increasing age (21%, 30%, and 61%, respectively; P=0.008). 
Conclusion: The 30-day and 5-year mortality in patients who survived rAAA was equal between 
the treatment options of eEVAR and OPEN. Particularly fragile and very elderly patients did 
not receive operative repair. The decision to intervene in rAAA should not be made on the basis 
of patient age alone, but also in relation to comorbidity and patient preference.
Keywords: ruptured abdominal aneurysm repair, clinical decision-making, emergency endo-
vascular aneurysm repair, open repair
Introduction
Rupture of an abdominal aortic aneurysm (AAA) is a catastrophic event, and is occur-
ring with increasing frequency in our increasingly elderly population.1 The demographic 
trend toward an aging population in the Western world and an increasing incidence and 
prevalence of cardiovascular disease in the elderly are important considerations for health 
care professionals. Although the established definition of “elderly patients” in the current 
literature refers to people aged over 65 years, current demographic trends, improved 
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health care, and understanding of the discrimination between 
biological age and chronological age dictates that the definition 
of an “elderly patient” may need to be revised. From a historical 
point of view, the conventional method used to repair a ruptured 
abdominal aortic aneurysm (rAAA) is open repair (OPEN) with 
replacement of the ruptured aneurysm using a synthetic tube 
graft. This extensive repair technique has a high mortality and 
morbidity rate in patients who are already reaching the limit of 
their physical reserves.2
Emergency endovascular aneurysm repair (eEVAR) is an 
alternative in patients with AAA and is becoming generally 
accepted in patients selected for planned AAA repair. The 
EVAR II trial reported no benefit for EVAR compared with 
no intervention in patients judged unfit for open elective AAA 
repair.3 However, several studies note that eEVAR could 
potentially reduce the morbidity and mortality rate.4–9 The 
minimally invasive nature of this technique allows aneurysm 
repair in patients with a rAAA who would be at significant 
risk in open surgery. Use of eEVAR could therefore be a 
viable alternative in patients suffering a rAAA, especially 
in the elderly. The current literature contains limited data on 
patients with a rAAA who arrive at hospital alive and do not 
receive emergency surgical repair. In our opinion, these data 
are of great importance in determining the outcome for elderly 
patients with rAAA who do and do not undergo emergency 
surgical repair. In this study, we analyzed our recent results for 
OPEN and eEVAR in rAAA patients, and describe patients 
who did not receive operative repair. We also investigated our 
results for rAAA repair in this elderly population according to 
age group.
Patients and methods
study design
This study was evaluated and approved by the institutional 
review board at our hospital. A retrospective observational 
clinical review was conducted using data on 157 consecu-
tive rAAA patients treated with OPEN or eEVAR between 
January 2005 and December 2011 in the vascular surgery 
department at Amphia Hospital, the Netherlands. Exclusion 
criteria were symptomatic AAA, acute onset of aortoduo-
denal fistula, and ruptured iliac aneurysm. Three patients 
who died prior to arrival in the operating theater were also 
excluded. Twelve patients did not receive operative emer-
gency repair and were treated conservatively.
Data analyzed per age group
All data collected for the included patients were analyzed 
according to age group: 70 years (group A, n=34, 32%), 
70–79 years (group B, n=59, 56%), and $80 years (group C, 
n=12, 11%). Operation-related 30-day mortality was defined 
as mortality in the first 30 days after surgical repair (eEVAR 
or OPEN); rAAA-related mortality was defined as mortality 
for all rAAA patients in the first 30 days after admission to 
our hospital regardless of whether or not they underwent 
operative repair (n=117).
risk factors and comorbidity
Risk factors, comorbidity, vital signs, and biochemistry tests 
were performed prospectively in all patients during their 
admission. Management of risk factors and comorbidity, 
according to the Trans-Atlantic Inter-Society Consensus 
Document on Management of Peripheral Arterial Disease10 
and the American Heart Association/American College of 
Cardiology,11 was undertaken by a vascular specialist or car-
diologist preoperatively whenever possible. Data on patient 
characteristics, risk factors, and comorbidity are listed in 
Table 1. An overview of rAAA patients with conservative 
management are shown in Table 2.
rAAA characteristics
The definition of rAAA used was hemorrhage outside the 
aortic wall and diagnosis by multislice computed tomogra-
phy (CT) (Siemens Definition scanner, Siemens, Munich, 
Germany). Some patients were hemodynamically unstable 
and no imaging could be performed, so the diagnosis was 
confirmed intraoperatively. Data on rAAA characteristics 
are shown in Table 1.
revascularization 
All vascular and endovascular procedures were performed 
by certified vascular surgeons and interventional radiologists 
who were available around the clock.
eeVAr
Two stent graft systems were used for treatment of rAAAs 
during the study periods: the Cook® Zenith Flex® aorto-
uni-iliac (AUI) device stent graft system (Cook Medical, 
Bloomington, IL, USA)12 in 2005–2008 and the Medtronic® 
Endurant® II AUI device (Medtronic Inc, Minneapolis, MN, 
USA) and aorto-bi-iliac stent graft system in 2008–2011.13 All 
AUI endografting was combined with femorofemoral cross-
over bypass and deployment of an occluder cuff in the contral-
ateral common iliac artery. The requirements for these standard 
available stent grafts were driven by the Society of Vascular 
Surgery/North American Chapter of the International Soci-
ety for Cardiovascular surgery (SVERSUS/ISCVERSUS)14 
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and the European Society for Vascular Surgery reporting 
standards.15 The eEVAR procedure was performed according 
to standard vascular and endovascular techniques.
It was recommended that eEVAR be performed under 
local anesthesia in the groin at the selected access site. After 
the AUI was inserted and antegrade flow into the rAAA sac 
was blocked, general anesthesia could be given to perform 
the subsequent operative steps, ie, deployment of the com-
mon iliac occluder cuff and completion of the femorofemoral 
crossover bypass. All patients met the criteria as listed in the 
instructions for use, according to component placement and 
sizing guidelines.
OPen
The OPEN procedure was performed according to stan-
dard vascular and endovascular techniques following the 
SVERSUS/ISCVERSUS guidelines.14 An anterior transperi-
toneal approach was used in all patients; after aortic clamp-
ing, a minimal dissection, and when necessary, intrasaccular 
ligation of the lumbar artery branches, was performed. 
Subsequently, suture attachment of the prosthetic graft to the 
proximal and distal aspects of the aneurysm was undertaken. 
Aortoaortic “straight tube” grafts and bifurcated prostheses 
were used. The operative data for patients who underwent 
OPEN or eEVAR are listed in Table 3. 
Admission and follow-up
general
Preoperative and operative data were collected. During 
follow-up, data on mortality, hospital (surgical ward) stay, 
and intensive care unit (ICU) stay were registered. Mortality 
data were retrieved using the national death registry. 
Adverse events
In the Netherlands, the Association of Surgeons of the 
Netherlands has agreed on one common definition of adverse 
events (AEs).16–20 This definition differs from that used in 
other studies because it has been chosen with the explicit 
Table 1 Characteristics of all patients treated for a rAAA by OPen or eeVAr in 2005–2011
Characteristics Total n=105 OPEN n=82 eEVAR n=23 P-value
Sex
Male
Female
Age
Median age, years (range)
70 
70–79 
$80 
HD-stable
SBP 80 mmHg
CT scan obtained
Yes
no
Diameter AAA
Median aneurysm, mm (range)
Comorbidity and risk factors
Cardiac disease
Pulmonary disease
renal disease
Diabetes mellitus
hypertension
hyperlipidemia
Peripheral arterial occlusive disease
Tobacco use
Secondary prevention
Antiplatelet agent
statin
86 (82)
19 (18)
73 (54–89)
34 (32)
59 (56)
12 (11)
48 (46)
61 (58)
80 (76)
25 (24)
80.0 (4.5–13.8)
47 (45)
29 (28)
10 (10)
12 (11)
51 (49)
12 (11)
8 (8)
44 (42)
42 (40)
35 (33)
69 (84)
13 (16)
71 (54–87)
33 (40)
40 (49)
9 (11)
37 (54)
45 (55)
57 (70)
25 (31)
80.0 (4.5–13.8)
37 (45)
22 (27)
8 (10)
7 (89)
38 (46)
11 (13)
6 (7)
37 (45)
31 (38)
27 (33)
17 (74)
6 (26)
77 (64–89)
1 (4)
19 (83)
3 (13)
11 (48)
16 (70)
23 (100)
0 (0)
70.0 (5.0–10.0)
10 (44)
7 (30)
2 (9)
5 (22)
13 (57)
1 (4)
2 (9)
7 (30)
11 (48)
8 (35)
0.260
0.260
0.001*
0.001*
0.004*
0.783
0.818
0.207
0.002*
0.002*
0.044*
0.889
0.733
0.878
0.079
0.388
0.227
0.826
0.429
0.386
0.867
Coumarins 13 (12) 12 (15) 1 (4) 0.180
Note: Data are presented as the n (%), unless otherwise specified. *P-value 0.05.
Abbreviations: AAA, abdominal aortic aneurysm; eeVAr, emergency endovascular aneurysm repair; OPen, open repair; hD-stable, hemodynamically stable; sBP, systolic 
blood pressure in mmhg; CT, computed tomography.
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aim of excluding subjective judgment on cause and effect, 
and right and wrong. The definition of an AE is: 
An unintended and unwanted event or state occurring during 
or following medical care, that is so harmful to a patient’s 
health that (adjustment of) treatment is required or that 
permanent damage results. The AE may be noted during 
hospitalization, until 30 days after discharge.20
endoleaks
The definition of endoleak, the decision to intervene, and 
the type of reintervention, ie, endovascular or surgical, 
were driven by the SVERSUS/ISCVERSUS14 and European 
Society for Vascular Surgery reporting standards and were 
registered.15
statistical analysis
The statistical analysis was performed using Statistical 
Package for the Social Sciences version 20 software (IBM 
Corporation, Armonk, NY, USA). Following completion 
of the data collection, univariate analyses were performed 
using the chi-square and unpaired Student’s t-tests. 
Survival was estimated by logistic regression analysis 
(30-day mortality) and Cox regression analysis (long-term 
mortality, with patients included to date of last follow-up 
or death).
Results
Patient selection process
Between January 2005 and December 2011, 157 patients 
were admitted to our hospital with a diagnosis of rAAA or 
Table 2 Patient overview for rAAA with conservative management (n=12)
Case HD-stable Age (years) Rationale for conservative management Time to mortality Time to mortality 
in hours
1 Yes 87 Medical history included AAA; decision for  
conservative treatment was made prior to  
rupture. 
48 hours 27
2 Yes 89 Diagnosis was confirmed with uncontrasted  
CT scan. Died 15 months later due to repeat  
rAAA. Complex morphology aneurysm. 
Conservative due to high age and  
comorbidity.
483 days (15 months) Unknown
3 Unknown 91 On demand of patient and family. 48 hours 33
4 no 92 Complex morphology aneurysm, not eeVAr  
suitable.
24 hours Unknown
5 no 87 Conservative management due to high age  
and comorbidity.
24 hours 4
6 no 83 Arrived undergoing CPr. Poor prognosis. 24 hours 2
7 Yes 85 Complex morphology aneurysm, not eeVAr  
suitable. On demand of patient and family, no  
open repair.
48 hours 32
8 no 89 Conservative due to high age and comorbidity  
including severe dementia.
48 hours 26
9 no 77 On demand of patient. history included  
end-stage prostate carcinoma.
48 hours 37
10 no 90 Due to high age. 48 hours 31
11 Yes 82 Complex morphology aneurysm, not eeVAr  
suitable. On demand of patient and family, no  
open repair due to high age and comorbidity.
24 hours 12
12 Yes 93 Due to high age and comorbidity, including  
severe cardiac failure.
24 hours 2
Abbreviations: AAA, abdominal aortic aneurysm; rAAA, ruptured abdominal aortic aneurysm; eeVAr, emergency endovascular aneurysm repair; hD-stable, hemodynamically 
stable; CT, computed tomography; CPr, cardiopulmonary resuscitation. 
Table 3 summary of OPen (n=82) and eeVAr procedures 
(n=23) in all patients treated for a rAAA
OPEN
Tube graft
Bi-iliac tube graft
Died prior to placement of graft
eEVAR
Cook® Zenith Flex® AAA (AUI) endovascular
graft system
Medtronic® endurant® AAA stent graft system
AUI stent graft system
58 (71)
19 (23)
5 (6)
12 (52)
5 (22)
ABI stent graft system 6 (26)
Note: Data are presented as n (%).
Abbreviations: rAAA, ruptured abdominal aortic aneurysm; OPen, open repair; 
eeVAr, emergency endovascular aneurysm repair; AUI, aorto-uni-iliac; ABI, 
aorto-bi-iliac.
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symptomatic AAA (Figure 1). Thirty-seven patients were 
excluded due to diagnosis of a symptomatic non-ruptured 
AAA. Twelve patients (mean age 87±4.6 years) did not 
undergo surgical intervention and were treated conserva-
tively for several different reasons, as listed in Table 2. One 
patient died after 15 months, and in this case a diagnosis of 
rAAA was confirmed by uncontrasted CT due to significant 
renal impairment. The remaining eleven patients died within 
48 hours (median mortality at 27 hours). Three patients 
died in the emergency room and were excluded. Of the 105 
patients included, 82 (78%) underwent OPEN and 23 (22%) 
received eEVAR.
Patient characteristics and comorbidity 
Patients in the eEVAR group were significantly older 
(median age 77 years) than those in the OPEN group (median 
age 71 years; P0.001). There were more men (n=69, 84%) 
in the OPEN group than in the eEVAR group (n=17, 74%; 
P=0.26). No difference in hemodynamic status at admission 
was detected between both groups. Comorbidity and risk 
factors were similar in both groups (Table 1). 
Characteristics of rAAA 
A CT scan was done in all 23 eEVAR patients and in 
57 OPEN patients (70%; P=0.002). The median rAAA diam-
eter in patients treated by eEVAR (70 mm) was significantly 
larger than in patients treated by OPEN (80 mm; P=0.044).
revascularization
In one patient, eEVAR was converted to an OPEN procedure 
due to persistent hemodynamic instability and development 
of a distended abdomen during surgery (Table 3). This patient 
died directly after completion of a celiotomy, most likely due 
to exsanguination. In another patient, eEVAR was converted 
to OPEN with placement of a tube graft due to technical 
problems during placement of the main device.
eeVAr-related reinterventions 
and endoleaks
We documented three type I, four type IIa, four type IIb, 
and two type III endoleaks, as shown in Table 4. No type IV 
or type V endoleaks were noted. Overstenting of four renal 
arteries occurred in three patients receiving eEVAR. Two 
patients underwent a Hartmann procedure because of bowel 
ischemia. Another two patients were reoperated because of 
an infected prosthesis (one with an infected EVAR and one 
with an infected femorofemoral crossover bypass). Other 
surgical adverse events and reinterventions are listed in 
Table 4. 
Adverse events and reinterventions
At least one AE occurred in the eEVAR and OPEN patients, 
(n=14 [61%] versus n=53 [65%]) respectively. There were 
more cardiac AEs in the OPEN group (n=25, 31%) than in 
the eEVAR group (n=2, 9%; P=0.035). Cerebrovascular acci-
dents occurred only in the eEVAR group (n=2, 9%; P=0.007), 
as shown in Table 5. There were more reinterventions dur-
ing follow-up in the rAAA patients who underwent eEVAR 
(n=8, 35%) than in those who underwent OPEN (n=5, 6%; 
P0.001), as indicated in Table 6.
length of stay
Hospital stay was not significantly longer in the OPEN group 
(mean 17 days) when compared with the eEVAR group 
(mean 12 days). Patients in both groups were admitted to 
the ICU for a mean of 7 days postoperatively. The data are 
summarized in Table 7.
Figure 1 Patient flow through identification and selection process.
Abbreviations: AAA, abdominal aortic aneurysm; eeVAr, emergency endovascular 
aneurysm repair; OPen, conservative open repair.
Registered ruptured AAA
n=157
Ruptured AAA
n=105
Operative treatment
n=105
eEVAR
n=23
OPEN
n=82
Symptomatic AAA
n=37
Conservative treatment
n=12 (Table 2)
Died prior to arrival in theater
n=3
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Table 4 summary of endoleaks and adverse events after all eeVAr procedures (n=23) in patients treated for a rAAA
Endoleak 
or surgical 
complication
Intraoperative 24 hours 30 days 3 months 12 months 12 months Further explanation
endoleak type 1 3a aOne died, one 
successfully treated by 
PTA, one treated by 
main device in main 
device placement.
endoleak type 2a 2 1 1b bligation of 2A.
endoleak type 2b 2 1c 1 cligation of IMA.
endoleak type 3 1d 1e dOccluder plug 
insufficient, coiling 
of 2A unsuccessful, 
ligation of eIA and 
femorofemoral 
crossover.
esurgical repair with 
interpositional graft.
Ischemic colitis 3f fTwo hartmann 
procedures, in one 
patient complicated  
by parastomal 
herniation 2 years 
after surgery.
Overstenting  
of renal artery 
3g 1 gIn one patient with a 
juxtarenal aneurysm 
and no open surgical 
possibilities due to 
severe intra-abdominal 
adhesions, 
overstenting of both 
renal arteries. 
Infected  
prosthesis
1h 1i hreoperation with 
replacement with 
an antibiotic drained 
prosthesis.
iInfected 
femorofemoral 
crossover with 
replacement with an 
autologous crossover 
bypass.
Aortoduodenal 
fistula
1j JConservative 
treatment, patient 
died.
Died on table  
after correct 
placement
1
Anastomotic 
aneurysm of 
femorofemoral 
crossover bypass
1 redone.
Note: All endoleaks and surgical complications were managed conservatively unless otherwise mentioned.
Abbreviations: eeVAr, emergency endovascular aneurysm repair; rAAA, ruptured abdominal aortic aneurysm; PTA, percutaneous transluminal angioplasty; 2A, internal 
iliac artery (hypogastric artery); IMA, inferior mesenteric artery; eIA, external iliac artery.
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Mortality
The 30-day mortality rate was 30% (7/23) in eEVAR patients 
versus 26% (21/82) in OPEN patients (P=0.64). Intraopera-
tive mortality was comparable in both groups; two patients 
(9%) died during eEVAR and nine patients during OPEN 
(11%; P=0.752). No difference in mortality in 1-year, 
3-year, and 5-year follow-up was found between eEVAR and 
OPEN. The data are summarized in Table 7.
Impact of age
There were fewer male patients (67%) in group C (age 
$80 years) than in group A (97%, age 70 years) and 
group B (76%, age 70–79 years; P=0.015). There were no 
significant differences in operation-related 30-day mortality 
(21%, 29%, and 33%) between groups A, B, and C, respec-
tively, if patients underwent surgery (Table 8). Increasing 
age was associated with mortality during 5-year follow-up 
(P=0.012, hazard ratio 1.049 [1.01–1.09]). The rAAA-related 
mortality increased with advancing age (21%, 30%, and 61% 
for groups A, B, and C, respectively; P=0.008). At least one 
AE occurred in 75% of patients in group C; however, there 
was no statistically significant difference when compared 
with the other age groups (Table 9). A survival curve per 
age group is shown in Figure 2. 
Discussion
Clinicians are being increasingly faced with fragile elderly 
patients in a poor mental and physical state. This problem is 
Table 5 Adverse events in all patients treated for a rAAA with eeVAr or OPen in 2005–2011
Description of adverse event Total n=105 OPEN n=82 eEVAR n=23 P-value
Any adverse event 67 (64) 53 (65) 14 (61) 0.740
Any cardiac Ae
Myocardial infarction
Cardiac arrest
heart failure
Brady/tachycardia
Atrial fibrillation
Any pulmonary Ae
Respiratory insufficiency
Pneumonia
Pleural fluid
Atelectasis
Any neurologic Ae
Cerebrovascular accident
neuropraxia
Any renal Ae
renal failure
renal failure hemodialysis
Urinary tract infection
Urinary retention
Wound infection
Wound dehiscence
Compartment syndrome 
Fascia dehiscence
Bowel ischemia
Bowel ischemia requiring resection
27 (26)
4 (4)
5 (5)
14 (13)
3 (3)
7 (7)
36 (34)
16 (15)
37 (35)
5 (5)
2 (2)
4 (4)
2 (2)
2 (2)
30 (29)
25 (24)
15 (14)
4 (4)
2 (2)
4 (4)
1 (1)
2 (2)
2 (2)
10 (10)
6 (6)
25 (31)
4 (5)
4 (5)
12 (15)
2 (2)
6 (7)
29 (35)
11 (13)
31 (38)
5 (6)
2 (2)
2 (2)
0 (0)
2 (2)
26 (32)
20 (24)
12 (15)
4 (5)
2 (2)
3 (4)
1 (1)
2 (2)
2 (2)
7 (9)
4 (5)
2 (9)
0 (0)
1 (4)
2 (9)
1 (4)
1 (4)
7 (30)
5 (22)
6 (26)
0 (0)
0 (0)
2 (9)
2 (9)
0 (0)
4 (7)
5 (22)
3 (13)
0 (0)
0 (0)
1 (4)
0 (0)
0 (0)
0 (0)
3 (13)
2 (9)
0.035*
0.280
0.916
0.459
0.627
0.614
0.660
0.326
0.299
0.225
0.450
0.316
0.007*
0.450
0.179
0.792
0.847
0.280
0.450
0.879
0.595
0.450
0.450
0.515
0.452
Infected tube graft 2 (2) 1 (1) 1 (4) 0.332
Notes: Data are presented as n (%). *P-value 0.05.
Abbreviations: Ae, adverse event; rAAA, ruptured abdominal aortic aneurysm; eeVAr, emergency endovascular aneurysm repair; OPen, open repair.
Table 6 reintervention rates with details of rAAA patients receiving OPen or eeVAr in 2005–2011
Intervention OPEN n=82 eEVAR n=23 P-value
Patients with any reintervention 26 (32) 11 (48) 0.153
reintervention during 30-day postoperative period 22 (27) 4 (17) 0.354
reintervention during follow-up 5 (6) 8 (35) 0.001
Note: Data are presented as the n (%).
Abbreviations: rAAA, ruptured abdominal aortic aneurysm; OPen, open repair; eeVAr, emergency endovascular aneurysm repair.
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Table 7 Mortality and hospital stay in all patients treated for a rAAA with eeVAr or OPen in 2005–2011
Total n=105 OPEN n=82 eEVAR n=23 P-value
Mortality
Intraoperative mortality
30-day mortality rate
1-year mortality rate
3-year mortality rate
5-year mortality rate
11/105 (10)
28/105 (27)
38/105 (36)
47/89 (53)
57/75 (76) 
9/82 (11)
21/82 (26)
30/82 (37)
37/70 (53)
44/58 (76)
2/23 (9)
7/23 (30)
8/23 (35)
10/19 (53)
13/17 (76)
0.752
0.644a
0.913b
0.913b
0.913b
Duration of in-hospital stay 
Mean (sD) length of hospital stay, days 16 (15) 17 (16) 12 (9) 0.212
Mean (sD) length of ICU stay in days 7 (11) 7 (11) 7 (12) 0.922
Notes: Data are presented as the n (%), unless otherwise specified; alogistic regression analysis; bCox regression analysis.
Abbreviations: rAAA, ruptured abdominal aortic aneurysm; OPen, open repair; eeVAr, emergency endovascular aneurysm repair; ICU, intensive care unit; sD, standard 
deviation.
Table 8 Operation-related mortality for a rAAA after eeVAr or OPen, and rAAA-related mortality per age group
Total  
All age groups
Group A  
Age 70 years 
Group B  
Age 70–79 years 
Group C  
Age $80 years
P-value HR (95% CI)
All rAAA patients treated 
with eEVAR or OPEN
n=105 n=34 n=59 n=12
Operation-related 30-day 
mortality rate
1-year mortality rate
28/105 (27)  
 
38/105 (36)
7/34 (21)  
 
11/34 (23)
17/59 (29)  
 
22/59 (37)
4/12 (33)  
 
5/12 (42)
0.059a  
 
0.012b
1.9 (0.45–8.30)  
 
1.049 (1.01–1.09)
3-year mortality rate
5-year mortality rate
47/89 (53)
57/75 (76)
13/28 (46)
16/24 (67)
27/51 (53)
31/41 (76)
7/10 (70)
10/10 (100)
0.012b
0.012b
1.049 (1.01–1.09)
1.049 (1.01–1.09)
All rAAA patients 
(treated operatively or 
nonoperatively)
n=117 n=34 n=60 n=23
rAAA-related 30-day  
mortality ratec
39/117 (33) 7/34 (21) 18/60 (30) 14/23 (61) 0.008a 6.0 (1.84–19.53)
Notes: Data are presented as the n (%). group A, age 70 years; group B, 70–79 years; group C, age $80 years. alogistic regression analysis. bCox regression analysis. 
cAddition of nonoperated patients with rAAA (n=117).
Abbreviations: rAAA, ruptured abdominal aortic aneurysm; OPEN, open repair; eEVAR, emergency endovascular aneurysm repair; HR, hazard ratio; CI, confidence interval.
of major importance, with population projections indicating 
that the number of persons aged over 80 years will double 
during the next 30 years.21 rAAA is associated with high 
mortality and significant comorbidity, especially in the 
very elderly.2 Supportive medical care for critically ill 
patients has improved over recent decades, and as support-
ive technologies become more advanced, surgeons should 
reconsider the expediency of comprehensive potentially 
life-saving interventions and extensive surgery in the elderly 
population. 
nonoperated patients
Interest in EVAR techniques has increased in recent years, 
and more studies noting potentially improved mortality and 
morbidity outcomes have been published. Every clinician 
who deals with vascular emergencies has experienced the 
ethical dilemma of whether to offer a probably hopeless 
but potentially life-saving intervention when a very elderly 
comorbid patient presents with a rAAA. The decision for 
OPEN or eEVAR in a rAAA case must be made according 
to the wishes of the patient and family, ie, whether to proceed 
with emergency repair or provide comfort measures. The 
decision should be made with serious consideration and care, 
and could be challenging because of the time factor. Evidence 
to guide this clinical decision is scarce in current literature. 
It has been reported that 10%–26% of patients with a rAAA 
who reach hospital alive are treated conservatively because 
of their extensive comorbidity and advanced age.22,23
There was a high mean age of 87 years in patients who 
were treated conservatively, compared with other studies 
reporting that 75% of the rAAA patients treated conser-
vatively were 80 years.24 In this study, advanced age in 
combination with frailty was mentioned most frequently as 
the reason for conservative treatment. As in the literature,24 
the average time to death following rAAA without repair 
was 7 hours. 
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Table 9 Data for patients treated for a rAAA with eeVAr or OPen after inclusion according to age group
Group A  
Age 70 years  
n=34 
Group B  
Age 70–79 years  
n=59
Group C  
Age $80 years  
n=12
P-value
Adverse events  
Any Ae 18 (53) 40 (68) 9 (75) ns
Any cardiac Ae 7 (21) 15 (25) 5 (42) ns
Any pulmonary Ae 10 (2) 21 (36) 5 (42) ns
Any neurologic Ae 0 (0) 2 (3) 2 (17) ns
Any renal Ae 8 (24) 18 (31) 4 (33) ns
Hospital stay
Mean (sD) length of ICU stay in days 3.9 (4) 8.6 (13) 6.4 (9) ns
Mean (sD) length of hospital stay in days 12.3 (7) 17.8 (17) 15.3 (20) ns
Notes: Data are presented as the n (%), unless otherwise specified. Group A, age 70 years; group B, 70–79 years; group C, age $80 years.
Abbreviations: Ae, adverse event; rAAA, ruptured abdominal aortic aneurysm; OPen, open repair; eeVAr, emergency endovascular aneurysm repair; ICU, intensive care 
unit; SD, standard deviation; NS, not statistically significant.
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Time to mortality in months
1.0
0.8
0.6
0.4
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Age groups
Age <70 years
Age 70–79 years
Age ≥80 years
Age <70 years-censored
Age 70–79 years-censored
Age ≥80 years-censored
Figure 2 survival per age group.
Notes: Kaplan–Meier curves representing survival per age group. Censored patients are patients where follow-up could not completed within 60 months because they were 
included at the end of the study period.
Abbreviation: se, standard error.
Age, years Months 0 10 20 30 40 50 60
70 Patients
se
34
0
23
0.08
22
0.082
16
0.083
13
0.083
10
0.097
8
0.097
70–79 Patients
se
59
0
36
0.063
35
0.064
27
0.065
21
0.066
17
0.068
10
0.075
$80 Patients
se
12
0
7
0.142
5
0.142
5
0.142
3
0.142
0
0.00
0
0.00
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Treatment: OPen and eeVAr
Adverse events
There were high AE rates in both treatment groups. In con-
trast with other studies, cardiac AEs were significantly more 
common in the OPEN group.25–29 These high rates could be 
explained partly by our broad definition and strict protocol 
for registration of AEs. Strokes occurred in the patients who 
received eEVAR, and this may be related to the guide wire in 
the aortic arch during the procedure. There was no significant 
difference in AEs per age group, and this could probably be 
explained by selection bias.
reinterventions
The risk of a reintervention and readmission is higher after 
eEVAR than after OPEN,30 particularly in very elderly 
patients. Edwards et al reported significant higher endovas-
cular reintervention rates in 3-year follow-up for patients 
with rAAA treated by eEVAR (10.9%) when compared with 
patients treated by OPEN (1.5%).31 Similarly, we report a rein-
tervention rate of 35% for patients treated by eEVAR and 6% 
for those treated by OPEN over 5 years of follow-up. A pos-
sible explanation is the fact that endoleaks and reinterventions 
for possible endoleaks occur only after eEVAR and not after 
OPEN. In contrast with our study, the literature reports that 
rAAA patients treated with eEVAR resulting in postoperative 
reinterventions had significant 30-day mortality.30 
hospital and ICU stay
In the current literature, there is significant heterogeneity 
with regard to reported hospital stay, ie, 9–15 days for 
eEVAR and 10–26 days for OPEN.29,32–35 We found no 
difference in the recorded hospital and ICU stay between 
patients treated with eEVAR or OPEN. Other studies have 
reported ICU stays of 0–5 days in eEVAR patients versus 
3–20 days in OPEN patients.36–45 This difference could 
be explained by the fact that the cited studies included 
fairly small patient groups. Also, in contrast with other 
studies, we excluded all patients without symptomatic 
rAAA, which is likely to reduce the length of ICU and 
hospital stay.
Mortality
No significant difference in 30-day mortality rates were 
detected between eEVAR and OPEN, which is consistent 
with a recent randomized controlled trial by Reimerink et al 
which included 116 cases and described a 30-day mortal-
ity rate of 25% and 21%, respectively.28 The IMPROVE 
trial (ClinicalTrials.gov identifier NCT01282996) reported 
similar results, describing no statistically significant 
 difference in 30-day mortality rates between rAAA-treated 
patients who underwent eEVAR (35.4%) and OPEN (37.4%). 
Remarkably, we found no statistically significant difference 
in 30-day operation-related mortality after differentiating per 
age group. This could be because we excluded extremely 
frail patients from operative treatment. Addition of patients 
with rAAA to our analysis, who did not receive operative 
repair, defined as rAAA-related mortality, resulted in sig-
nificantly higher mortality among octogenarians than in 
younger patients. With appropriate selection, we consider 
that octogenarians in good condition could have the same 
outcome as younger patients undergoing emergency opera-
tive repair for rAAA. However, rAAA is more frequent in 
males. Further, in most Western societies, life expectancy is 
known to be shorter for males compared with females and a 
higher mortality is expected, so this should be borne in mind 
when interpreting these results.
Current studies on quality of life after EVAR in octo-
genarians report that recovery to the baseline level of func-
tioning seems to last at least 1 year.46 However, quality of 
life is probably even more impaired after OPEN. Despite 
acceptable outcomes in selected elderly patients, results in 
terms of quality of life should be taken into account in clinical 
decision-making with regard to whether or not to intervene 
in a case of rAAA.
limitations
Because of its retrospective nature, our study has some limita-
tions that should be considered when interpreting its results. 
Patients considered unstable on arrival to hospital did not 
receive CT scanning and were taken directly to the operat-
ing theater for OPEN, and this contributes to a significant 
selection bias. Anatomic suitability was certainly a source 
of significant bias in this study, as it is certainly the main 
determining factor regarding whether to perform eEVAR or 
not. Indeed, anatomic suitability also significantly influenced 
the decision whether or not to operate, as mentioned earlier. 
The number of patients in the present study does not permit 
further analyses, particularly given that the numbers of 
octogenarian patients included were small. Another possible 
limitation of this study may be the restriction of data col-
lection to only one hospital, which might not be completely 
representative for all hospitals.
Conclusion
The 30-day and 5-year mortality rates following survival 
of patients with rAAA are similar for eEVAR and OPEN, 
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despite the increased cardiac morbidity after OPEN. No major 
increase in 30-day mortality with age could be observed in 
octogenarians undergoing surgical repair in this study. How-
ever, particularly frail and very elderly patients receive no 
rAAA repair. Selection as to whether to intervene in a case 
of rAAA should not be made on the basis of age alone, but 
also in relation to comorbidity and patient preference. 
Disclosure
The authors report no conflicts of interest in this work.
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